Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Shares Outstanding (Weighted Average) (2018 - 2025)

Outset Medical (OM) has disclosed Shares Outstanding (Weighted Average) for 7 consecutive years, with $15211.0 as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Weighted Average) rose 339.24% to $15211.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $15211.0, a 339.24% increase, with the full-year FY2025 number at $15211.0, up 339.24% from a year prior.
  • Shares Outstanding (Weighted Average) was $15211.0 for Q4 2025 at Outset Medical, up from $14228.0 in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $49364.0 in Q3 2023 to a low of $3305.0 in Q4 2023.
  • A 5-year average of $29427.2 and a median of $43494.0 in 2021 define the central range for Shares Outstanding (Weighted Average).
  • Peak YoY movement for Shares Outstanding (Weighted Average): crashed 99.38% in 2021, then surged 417.89% in 2025.
  • Outset Medical's Shares Outstanding (Weighted Average) stood at $45589.0 in 2021, then grew by 5.64% to $48161.0 in 2022, then crashed by 93.14% to $3305.0 in 2023, then grew by 4.78% to $3463.0 in 2024, then surged by 339.24% to $15211.0 in 2025.
  • Per Business Quant, the three most recent readings for OM's Shares Outstanding (Weighted Average) are $15211.0 (Q4 2025), $14228.0 (Q3 2025), and $17743.0 (Q2 2025).